Loading...

Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

CONTEXT: In postmenopausal osteoporosis, combining denosumab and teriparatide increases hip and spine bone mineral density more than either monotherapy. OBJECTIVE: The objective of the study was to determine the effects of 2 years of combination therapy on bone microarchitecture and estimated streng...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Endocrinol Metab
Main Authors: Tsai, J. N., Uihlein, A. V., Burnett-Bowie, S. M., Neer, R. M., Derrico, N. P., Lee, H., Bouxsein, M. L., Leder, B. Z.
Format: Artigo
Sprog:Inglês
Udgivet: Endocrine Society 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4870854/
https://ncbi.nlm.nih.gov/pubmed/26964731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2016-1160
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!